StockTipsArenaBeta

Concord Biotech Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,270-15.80 (-1.23%)
As of 21 Oct 2026
No positional price targets right nowLast 1-year target: ₹1,750 from Siddharth Rai Mangala (21 Sept 2026) · stop-loss hit
0
none open right now
—
no positional targets
N/A
9 of 10 closed calls needed
9
all horizons, open and closed
Watch CONCORDBIO for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (9)

BUYTarget₹1,750
SRbySiddharth Rai MangalaStop-loss hit
1 Year · 21 Sept 2026 · entry ₹1,561.5 · via Zee Business (Live)exit ₹1,480
BUYTarget₹1,610
AJbyAnsh Jogendra BhilwarStop-loss hit
1 Year* · 2 Sept 2026 · entry ₹1,485 · via Zee Business (Live)exit ₹1,424
BUYTarget₹1,460
RVbyRaja VenkatramanTarget hit
1–3 Months · 30 Jul 2026 · entry ₹1,335 · via LiveMint Buy-or-Sell (topic)exit ₹1,460
BUYTarget₹1,685
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 21 Sept 2026 · entry ₹1,546 · via IDBI Capital Research Calls Telegramexit ₹1,475
BUYTarget₹1,450
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 13 Jul 2026 · entry ₹1,330 · via IDBI Capital Research Calls Telegramexit ₹1,270
BUYTarget₹1,375
AJbyAnshul Jain, Lakshmishree Investment and SecuritiesTarget hit
1–2 Weeks* · 29 Jul 2026 · entry ₹1,356 · via Business Todayexit ₹1,375
BUYTarget₹1,717
SJbySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesStop-loss hit
1–2 Weeks · 15 Sept 2026 · entry ₹1,513.6 · via NDTV Profit (Live)exit ₹1,399
BUYTarget₹1,650
SBbySumeet Bagadia, Choice BrokingExpired
1–2 Weeks* · 18 Aug 2026 · entry ₹1,565.7 · via LiveMint Buy-or-Sell (topic)exit ₹1,447
BUYTarget₹1,550
OKbyOsho Krishan, Angel OneExpired
1–2 Weeks* · 4 Aug 2026 · entry ₹1,428.8 · via ET Nowexit ₹1,520.1

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks